EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Overcoming proteasome inhibitor resistance in the immunotherapy era

Bonell Patiño-Escobar, Alexis Talbot, Arun P Wiita

Trends in Pharmacological Sciences · 2023-08 · 44 (8) · 507-518

DOI: 10.1016/j.tips.2023.05.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2023-08. Verfasst von Bonell Patiño-Escobar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Proteasome Inhibitors, Multiple Myeloma. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteasome InhibitorsMultiple MyelomaHumansMitochondriaImmunotherapyDrug Resistance, Neoplasm

Stichwörter der Autor:innen

immunotherapymyelomaproteasome inhibitorresistance

Substanzen

Proteasome Inhibitors

Autor:innen und Institutionen

  • Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; INSERM U976, Institut de Recherche Saint Louis, Université de Paris, Paris, France.
  • Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA;…

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • National Cancer Institute
  • Multiple Myeloma Research Foundation

Zitieren

APA

Patiño-Escobar, B., Talbot, A., & Wiita, A. P. (2023). Overcoming proteasome inhibitor resistance in the immunotherapy era. Trends in Pharmacological Sciences, 44(8), 507-518. https://doi.org/10.1016/j.tips.2023.05.006

Vancouver

Patiño-Escobar B, Talbot A, Wiita AP. Overcoming proteasome inhibitor resistance in the immunotherapy era. Trends in Pharmacological Sciences. 2023;44(8):507-518. doi:10.1016/j.tips.2023.05.006

BibTeX
@article{PatioEscobar2023,
  author = {Patiño-Escobar, Bonell and Talbot, Alexis and Wiita, Arun P},
  title = {Overcoming proteasome inhibitor resistance in the immunotherapy era},
  journal = {Trends in Pharmacological Sciences},
  year = {2023},
  volume = {44},
  number = {8},
  pages = {507--518},
  doi = {10.1016/j.tips.2023.05.006}
}
Kostenlos starten →